Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with Factor IX-fusion protein or N9-GP extended half-life Factor IX concentrates
Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with Factor IX-fusion protein or N9-GP extended half-life Factor IX concentrates. // Journal of Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S1538783626005325?dgcid=rss_sd_all
Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with Factor IX-fusion protein or N9-GP extended half-life Factor IX concentrates. Journal of Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S1538783626005325?dgcid=rss_sd_all
“Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with Factor IX-fusion protein or N9-GP extended half-life Factor IX concentrates.” Journal of Thrombosis and Haemostasis.
@article{article56265,
title = {Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with Factor IX-fusion protein or N9-GP extended half-life Factor IX concentrates},
journal = {Journal of Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S1538783626005325?dgcid=rss_sd_all}
}